Title of article
Successful Treatment of Chronic Myelogenic Leukemia (CML) with Imatinib after Renal Transplantation
Author/Authors
Eishei Oskuei, Ali Uromia University of Medical Sciences, ايران , Makhdoomi, Khadijeh Nephrology and Kidney Transplant Research Center, ايران , Abkhiz, Saeed Uromia University of Medical Sciences, ايران , Vossoghian, Sara Uromia University of Medical Sciences, ايران , Farrokhpour, Mohsen Uromia University of Medical Sciences, ايران
From page
388
To page
390
Abstract
Chronic Myelogenic Leukemia (CML) is a rare malignant disorder after solid organ transplantation, especially in renal transplant recipi- ents. lmatinib Mesylate is currently approved as first line treatment of CML. Most reports on CML are from kidney recipients who received azathioprine in combination with cyclosporine and prednisolone as immunosuppressive therapy. We report a case with CML who was treated with Mycophenolate Mofetil.
Keywords
Chronic myelogenic leukemia , imatinib , renal transplant
Journal title
Archives of Iranian Medicine
Journal title
Archives of Iranian Medicine
Record number
2545360
Link To Document